Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TRANSITION THERAPEUTICS INC. T.TTH

Healthcare Biotechnology
"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."

Recent & Breaking News (TSX:TTH)

Transition Therapeutics Enters Osteoarthritis License and Collaboration Agreement with Lilly

Canada NewsWire July 23, 2013

Five Star Equities Issues New Research Reports on CHKP, ERIC, JCI and TTHI

Accesswire July 22, 2013

FDA Grant Fast Track Designation to ELND005 for the Treatment of Neuropsychiatric Symptoms in Alzheimer's Disease

Canada NewsWire July 17, 2013

Transition Therapeutics to Present at 8th Annual JMP Securities Healthcare Conference

Canada NewsWire July 8, 2013

Transition Therapeutics to Present at 8th Annual JMP Securities Healthcare Conference

PR Newswire July 8, 2013

Transition Therapeutics Announces Exercise of TT-401 Rights by Lilly

Canada NewsWire June 17, 2013

Transition Therapeutics Announces Exercise of TT-401 Rights by Lilly

PR Newswire June 17, 2013

Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial Results

PR Newswire May 7, 2013

Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial Results

Canada NewsWire May 7, 2013

Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. EST

Canada NewsWire May 6, 2013

Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. EST

PR Newswire May 6, 2013

InvestorsGuru.com 46 Filtered Mid-Day Market Movers Recap

Investors Guru May 5, 2013

Free Research Reports on DDD, ESRX, NBS and TTHI Issued by the Bedford Report

Marketwired May 1, 2013

Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401

Canada NewsWire April 30, 2013

Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401

PR Newswire April 30, 2013

Transition Therapeutics Announces Second Quarter Fiscal 2013 Financial Results

Canada NewsWire February 7, 2013

Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2013 Financial Results on Thursday, February 7th, at 4:30 P.M. EST

Canada NewsWire February 4, 2013